Back
Evotec SE 10K Form
Sell
49
EVOTF
Evotec SE
Last Price:
7.10
Seasonality Move:
-12.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EVOTF News And Ratings
See the #1 stock for the next 7 days that we like better than EVOTF
EVOTF Financial Statistics
Sales & Book Value
| Annual Sales: | $845.98M |
|---|---|
| Cash Flow: | $-96.16M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.11 |
| Price / Book: | 1.16 |
Profitability
| EPS (TTM): | -1.04820 |
|---|---|
| Net Income (TTM): | $-184.46M |
| Gross Margin: | $189.51M |
| Return on Equity: | -15.37% |
| Return on Assets: | -7.75% |
Evotec SE Earnings Forecast
Key Evotec SE Financial Ratios
- The Gross Profit Margin over the past 19 years for EVOTF is 22.40%.
- The Selling, General & Administrative Expenses for EVOTF have been equal to 21.71% of Gross Profit Margin.
- The Research & Development expenses have been 7.36% of Revenue.
- The Interest Expense is -13.99% of Operating Income.
- The Net Earning history of EVOTF is -10.74% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 11 years.
Evotec SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | EVOTF |
| Website: | evotec.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 1.83 |
| Quick Ratio: | 1.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |